pubmed-article:1362374 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1362374 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:1362374 | lifeskim:mentions | umls-concept:C0014792 | lld:lifeskim |
pubmed-article:1362374 | lifeskim:mentions | umls-concept:C0006983 | lld:lifeskim |
pubmed-article:1362374 | lifeskim:mentions | umls-concept:C1523924 | lld:lifeskim |
pubmed-article:1362374 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
pubmed-article:1362374 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
pubmed-article:1362374 | lifeskim:mentions | umls-concept:C0028580 | lld:lifeskim |
pubmed-article:1362374 | lifeskim:mentions | umls-concept:C0443172 | lld:lifeskim |
pubmed-article:1362374 | lifeskim:mentions | umls-concept:C0205266 | lld:lifeskim |
pubmed-article:1362374 | lifeskim:mentions | umls-concept:C0686907 | lld:lifeskim |
pubmed-article:1362374 | lifeskim:mentions | umls-concept:C1655045 | lld:lifeskim |
pubmed-article:1362374 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:1362374 | pubmed:dateCreated | 1993-2-17 | lld:pubmed |
pubmed-article:1362374 | pubmed:abstractText | Because the exact mechanism of action of carbimazole is uncertain, nuclear magnetic resonance (NMR) spectroscopy was used to investigate cellular changes in erythrocytes from Graves' patients following a course of carbimazole therapy. | lld:pubmed |
pubmed-article:1362374 | pubmed:language | eng | lld:pubmed |
pubmed-article:1362374 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1362374 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1362374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1362374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1362374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1362374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1362374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1362374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1362374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1362374 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1362374 | pubmed:month | Oct | lld:pubmed |
pubmed-article:1362374 | pubmed:issn | 0300-0664 | lld:pubmed |
pubmed-article:1362374 | pubmed:author | pubmed-author:WilsonRR | lld:pubmed |
pubmed-article:1362374 | pubmed:author | pubmed-author:ThomsonJ AJA | lld:pubmed |
pubmed-article:1362374 | pubmed:author | pubmed-author:McKillopJ HJH | lld:pubmed |
pubmed-article:1362374 | pubmed:author | pubmed-author:SmithW EWE | lld:pubmed |
pubmed-article:1362374 | pubmed:author | pubmed-author:ReglinskiJJ | lld:pubmed |
pubmed-article:1362374 | pubmed:author | pubmed-author:BuchananL MLM | lld:pubmed |
pubmed-article:1362374 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1362374 | pubmed:volume | 37 | lld:pubmed |
pubmed-article:1362374 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1362374 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1362374 | pubmed:pagination | 319-24 | lld:pubmed |
pubmed-article:1362374 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:meshHeading | pubmed-meshheading:1362374-... | lld:pubmed |
pubmed-article:1362374 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1362374 | pubmed:articleTitle | Spin echo nuclear magnetic resonance studies on intact erythrocytes: changes in cellular metabolism as a consequence of carbimazole therapy. | lld:pubmed |
pubmed-article:1362374 | pubmed:affiliation | Department of Pure and Applied Chemistry, Strathclyde University, Glasgow, UK. | lld:pubmed |
pubmed-article:1362374 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1362374 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |